SAGA token experiences 157% fluctuation in 24 hours: trading volume surges over 500 million USD, driving extreme volatility
Bitget Pulse2026/05/13 16:02Brief on Volatility
In the past 24 hours, SAGA price surged from a low of $0.0265 to a high of $0.0681, with the current quote at $0.0276, achieving an amplitude of 157.0%. Trading volume skyrocketed to approximately $563 million USD, up over sevenfold compared to the previous day; there are clear signs of net capital inflow accompanied by whale accumulation activity.
Summary of Reasons for the Price Movement
• Surging trading and open interest volumes: 24-hour spot trading volume exceeded $390 million USD, futures trading volume was nearly $2 billion USD, and the volume/market cap ratio reached as high as 21x, driving an extreme price rally.
• Whale & derivatives activity: The combination of whale accumulation and spot & derivatives trading frenzy led to a rapid increase in open interest within 24 hours, causing a pump followed by a swift pullback.
No official announcements or major on-chain events (such as SagaEVM reopening is old news).
Market View and Outlook
The mainstream community sentiment is short-term excitement (“parabolic” rally), with Binance Square and other platforms discussing +111%~171% surges, but analysts warn of an overbought RSI and evident profit-taking, predicting high volatility or further correction to the $0.02 area. Caution is advised regarding low-cap meme-style pump risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
